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The biology of cardiac and peripheral ischemia and reper-
fusion (IR) injury is extremely complex, and the vascular
endothelium plays a central role both in protecting from
ischemic damage as well as in mediating this damage. Due
to its strategic location and its intense biosynthetic activ-
ity, the vascular endothelium is particularly sensitive to
IR: the endothelium is the first tissue damaged by IR, and
human in vivo models of isolated endothelial IR injury
have been developed that allow investigating the mecha-
nisms of this phenomenon. Particularly during reper-
fusion, the rapid formation of superoxide anion and other
reactive oxygen species causes endothelial damage, lead-
ing to the so-called no-reflow phenomenon. In this way,
the endothelium determines permanent impairment to
tissue reperfusion, extending the ischemic damage. At the
same time, the endothelium, like any other tissue, can be
preconditioned against IR damage, i.e., it is able to
develop a protective phenotype that defends itself and the
tissues from IR. We will discuss how the endothelium is
the first casualty in the setting of IR, and at the same time
how this tissue can be protected by physical and pharma-
cological stimuli, which opens new therapeutic possibili-
ties.
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